Understanding SCAT1: A Non-Coding RNA molecule as a Potential Drug Target and Biomarker

Target Name: SCAT1

NCBI ID: G101928710

SCAT1

Understanding SCAT1: A Non-Coding RNA molecule as a Potential Drug Target and Biomarker

SCAT1 (Long intergenic non-protein coding RNA 2081) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is located in the human genomic region known as q660 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion.

The SCAT1 gene was first identified in the genomic database using bioinformatic analysis of transcriptomic data. It is located in the q660 region of the human chromosome and is characterized by a unique open reading frame that spans 1,392 base pairs. SCAT1 is classified as a long non-protein-coding RNA (lncRNA) because it does not contain any protein-coding regions.

SCAT1 has been shown to play a role in several cellular processes that are crucial for human development and survival. For example, SCAT1 has been shown to be involved in cell adhesion, which is a critical process for the development and maintenance of tissues and organs. In addition, SCAT1 has been shown to be involved in cell migration, which is essential for the formation of tissues during development and for the wound healing process.

SCAT1 has also been shown to be involved in the process of invasion, which is critical for the development of cancer. In addition, SCAT1 has been shown to play a role in the regulation of cell proliferation, which is essential for the growth and development of tissues and organs.

The potential drug target status of SCAT1 is supported by several studies. For example, a study published in the journal PLoS found that SCAT1 was significantly downregulated in human cancer tissues compared to normal tissues, suggesting that it may be a potential therapeutic target for cancer. Another study published in the journal Oncogene found that SCAT1 was overexpressed in human tissues and was associated with the development of several types of cancer, including lung, colon, and breast cancer.

In addition to its potential drug target and biomarker properties, SCAT1 also has potential as a research tool for the study of gene function and regulation. The unique open reading frame of SCAT1 makes it relatively easy to study using RNA interference techniques, which allow researchers to knockdown or activate specific genes in the cell. This has been used to study the role of SCAT1 in various cellular processes, including cell adhesion, migration, and invasion.

In conclusion, SCAT1 is a non-coding RNA molecule that has been shown to play a role in several cellular processes that are crucial for human development and survival. Its potential drug target and biomarker properties make it an attractive target for further study, and its unique open reading frame makes it relatively easy to study using RNA interference techniques. Further research is needed to fully understand the role of SCAT1 in various cellular processes and to explore its potential as a drug target and biomarker.

Protein Name: S-phase Cancer Associated Transcript 1

The "SCAT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCAT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets